Rodec Pharma Limited

Rodec Pharma Limited IPO: GMP, Profit, Price & expert review

by

Rodec Pharma Limited is a veterinary healthcare and animal nutrition company engaged in the manufacturing of animal feed supplements and the marketing of veterinary pharmaceutical drugs and feed supplements.
The products are designed to address the healthcare and nutritional requirements of livestock animals, veterinarians, and animal healthcare providers.

It operates through consignee agents, 400+ stockists and 400+ sales representatives across 15+ Indian states, serving veterinarians and livestock farmers nationwide.

Rodec Pharma Limited has filed DRHP with SEBI for a proposed IPO with an issue size of 56,50,000 Equity Shares consisting entirely as an Offer for Sale (OFS) of 56,50,000 Equity Shares and no Fresh Issue.

Subscription date to apply for the IPO is yet to be announced. Price band for the IPO is also pending to be declared.

Check DRHP
Check IPO Allotment
Visit Official Website
Issue Size:56,50,000 Equity Shares
Fresh Issue:₹ 00 Cr
Offer for Sale:56,50,000 Equity Shares
Price Range:TBA
Lot Size:TBA
GMPPending

Rodec Pharma Limited important data points

Revenue, PAT, EBITDA

YearFiscal 2025
Networth₹ 50 Cr
Revenue:₹ 106.4 Cr
EBITDA₹ 25.8 Cr
PAT₹ 18.3 Cr
EBITDA Margin:~24.21%
PAT Margin~ 17.16%
Face Value:Rs. 10 per Equity Share

IPO important dates

Open Date:TBA
Close Date:TBA
Anchor Investor BiddingTBA
Allotment Date:TBA
Refunds & Demat CreditTBA
Tentative Listing Date:TBA

Use of Proceeds

PurposeAmount
Borrowing repayment/prepayment~ ₹ 00 Cr
Setting up New Project~ ₹ 00 Cr
Working capital requirements~ ₹ 00 Cr
General Corporate Purpose~ ₹ 00 Cr

Rodec Pharma Limited Financial Data

202320242025
Revenue (₹ Cr)₹ 71.6₹ 88.4₹ 106.4
PAT (₹ Cr)₹ 5.2₹ 11.0₹ 18.3
Asset (₹ Cr)₹ 44.1₹ 50.6₹ 72.0
Net Worth (₹ Cr)₹ 20.7₹ 31.7₹ 50.0

Rodec Pharma Ltd IPO Grey Market Premium

DateIPO PriceIPO GMPProfit per lot
25-Feb₹ –₹ –₹ –
24-Feb₹ –₹ –₹ –
23-Feb₹ –₹ –₹ –
22-Feb₹ –₹ –₹ –
21-Feb₹ –₹ –₹ –
Rodec Pharma Limited

Rodec Pharma Limited IPO Pros & Cons

Strengths:

  • Operates in the growing animal healthcare & livestock nutrition sector.
  • Experienced promoter & management with decades in veterinary pharma.
  • Wide distribution network across multiple Indian states.
  • Diverse product portfolio covering pharma drugs and feed supplements.
  • Increasing focus on animal health and dairy productivity in India.

Risks:

  • IPO is 100% Offer for Sale (OFS) with no fresh funds for business growth.
  • No disclosed market share, making competitive positioning unclear.
  • Business is highly dependent on livestock industry cycles.
  • Limited brand visibility compared to large veterinary pharma peers.
  • Revenue may be impacted by regulatory and pricing controls in animal healthcare.

Rodec Pharma Limited Promoters – Pre offer equity (Approx)

Promoters%Shares
Mukesh Kumar Gupta~51.38%
Chhaya Gupta~25.19%
Utkarsh Gupta~13.61%

Rodec Pharma Limited Lot Size details

Application TypeLot SizeNo. of LotsNo. of SharesInvestment Amount
Retail(Min)–1–₹ –
Retail (Max)–13–₹ –
Small HNI (Min)–14–₹ –
Small HNI (Max)–66–₹ –
Big HNI (Min)–67–₹ –

Lead Managers / Registrars of Rodec Pharma Limited 

Lead / Book Running Lead ManagersKhambatta Securities Limited
Registrar (RTA)Bigshare Services Private Limited

Founding Year of Rodec Pharma Limited & Managing Director

Rodec Pharma Limited was incorporated in the year 1997.

Mr. Mukesh Kumar Gupta serves as the Managing Director of the company.

Rodec Pharma Limited FAQ

For more amazing blogs click here (IPO Corner).

facebookShare on Facebook
TwitterPost on X
FollowFollow us
PinterestSave

Leave a comment

RSS
Follow by Email
Facebook
X (Twitter)
Pinterest
Instagram
Telegram
WhatsApp